Search

Search results

560 results found

Sarah Pitafi

Person: Research Scholar, MeRGE Research Lab

Sarah Pitafi is a third year medical student at Harvard highly interested in women's health and health policy/advocacy. Previously, she studied Ethics, Politics, and Economics at Yale, and obtained an MA in Philosophy, Politics, and Economics of Health as a Fulbright Scholar. Outside the lab, she is...

Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease.

Publication: Journal Article

Naderian, Mohammadreza, Jun Li, Yulanka Castro-Dominguez, Tarek Hammad, Clint Oommen, Herbert D Aronow, Eric A Secemsky, and Mehdi H Shishehbor. 2025. “Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease.”. Journal of the Society for Cardiovascular Angiography & Interventions 4 (9): 103816.

Comprehensive characterization of the real-world perioperative morbidity of radical cystectomy in older adults

Publication: Bill

Gershman, B., J. Ernandez, S. Kaul, A. Perez-Londono, A. Fleishman, R. Korets, P. Chang, et al. 2025. Comprehensive Characterization of the Real-World Perioperative Morbidity of Radical Cystectomy in Older Adults.

Enhanced prostatic Esr1(+) luminal epithelial cells in the absence of SRD5A2

Publication: Bill

Sharkey, C., X. Long, R. Al-Faouri, D. Strand, A. F. Olumi, and Z. Wang. 2024. Enhanced Prostatic Esr1(+) Luminal Epithelial Cells in the Absence of SRD5A2.

Involvement of FLIP in 2-methoxyestradiol-induced tumor regression in transgenic adenocarcinoma of mouse prostate model

Publication: Bill

Ganapathy, M., R. Ghosh, X. Jianping, X. Zhang, R. Bedolla, J. Schoolfield, I. T. Yeh, D. A. Troyer, A. F. Olumi, and A. P. Kumar. 2009. Involvement of FLIP in 2-Methoxyestradiol-Induced Tumor Regression in Transgenic Adenocarcinoma of Mouse Prostate Model.

Management of spermatic cord tumors: a rare urologic malignancy

Publication: Bill

Rodríguez, D., and A. F. Olumi. 2012. Management of Spermatic Cord Tumors: A Rare Urologic Malignancy.

Personalized medicine for the management of benign prostatic hyperplasia

Publication: Bill

Bechis, S. K., A. G. Otsetov, R. Ge, and A. F. Olumi. 2014. Personalized Medicine for the Management of Benign Prostatic Hyperplasia.

Prognostic significance of indeterminate lung nodules in renal cell carcinoma

Publication: Bill

Xu, R., N. Horick, F. J. McGovern, D. M. Dahl, A. S. Feldman, M. L. Blute, A. F. Olumi, and M. D. Michaelson. 2014. Prognostic Significance of Indeterminate Lung Nodules in Renal Cell Carcinoma.

Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia

Publication: Bill

Bechis, S. K., A. G. Otsetov, R. Ge, Z. Wang, M. G. Vangel, C. L. Wu, S. Tabatabaei, and A. F. Olumi. 2015. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.

Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma

Publication: Bill

Cornejo, K. M., M. Lu, P. Yang, S. Wu, C. Cai, W. D. Zhong, A. Olumi, R. H. Young, and C. L. Wu. 2015. Succinate Dehydrogenase B: A New Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.